Concepedia

Antonio Mulero‐Sánchez

AM

Statistics

Publications

6

Citations

826

H-Index

6

Active since

2018

Affiliations

The Netherlands Cancer Institute(Current)

Oncode Institute

Renji Hospital

Shanghai Cancer Institute

State Key Laboratory of Oncogene and Related Genes

Antonio Mulero‐Sánchez is an author at The Netherlands Cancer Institute specializing in medicine, cancer research, and liver physiology.

ORCID

Top concepts

Publications per year

2018–2024

6

Publications

6

Inducing and exploiting vulnerabilities for the treatment of liver cancer

Cun Wang, Serena Vegna, Haojie Jin et al. · Nature · 2019 · 417 citations

, , +9

SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo

Sara Mainardi, Antonio Mulero‐Sánchez, Anirudh Prahallad et al. · Nature Medicine · 2018 · 312 citations · Full text

, , +9

Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy

Matheus Henrique Dias, Anoek Friskes, Siying Wang et al. · Cancer Discovery · 2024 · 41 citations · Full text

Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer

Katrin J. Frank, Antonio Mulero‐Sánchez, Alexandra Berninger et al. · Cell Reports Medicine · 2022 · 33 citations · Full text

Rational combination of <scp>SHP2</scp> and <scp>mTOR</scp> inhibition for the treatment of hepatocellular carcinoma

Antonio Mulero‐Sánchez, Christel Ramirez, Aimée du Chatinier et al. · Molecular Oncology · 2023 · 13 citations · Full text

, , +22

1–5 of 6